BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15955106)

  • 1. The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells.
    Hoeller C; Thallinger C; Pratscher B; Bister MD; Schicher N; Loewe R; Heere-Ress E; Roka F; Sexl V; Pehamberger H
    J Invest Dermatol; 2005 Jun; 124(6):1293-9. PubMed ID: 15955106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
    Li J; Sidell N
    Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.
    Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC
    Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
    Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
    Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
    Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
    Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcgammaRIIA exogenously expressed in HeLa cells activates the mitogen-activated protein kinase cascade by a mechanism dependent on the endogenous expression of the protein tyrosine kinase Syk.
    Renedo MA; Fernández N; Crespo MS
    Eur J Immunol; 2001 May; 31(5):1361-9. PubMed ID: 11465093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein tyrosine kinase syk activity is reduced by clustering the mast cell function-associated antigen.
    Xu R; Pecht I
    Eur J Immunol; 2001 May; 31(5):1571-81. PubMed ID: 11465115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation.
    Rao N; Ghosh AK; Ota S; Zhou P; Reddi AL; Hakezi K; Druker BK; Wu J; Band H
    EMBO J; 2001 Dec; 20(24):7085-95. PubMed ID: 11742985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
    Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
    Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: extracellular signal-regulated kinase activates syk: a new potential feedback regulation of Fc epsilon receptor signaling.
    Xu R; Seger R; Pecht I
    J Immunol; 1999 Aug; 163(3):1110-4. PubMed ID: 10415002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction.
    Zoller KE; MacNeil IA; Brugge JS
    J Immunol; 1997 Feb; 158(4):1650-9. PubMed ID: 9029101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor-dependent myeloid cells.
    Gotoh A; Takahira H; Geahlen RL; Broxmeyer HE
    Cell Growth Differ; 1997 Jun; 8(6):721-9. PubMed ID: 9186005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
    Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
    Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
    Wang HY; Zhang ZX
    Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
    Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro properties of human melanoma cells metastatic in nude mice.
    Herlyn D; Iliopoulos D; Jensen PJ; Parmiter A; Baird J; Hotta H; Adachi K; Ross AH; Jambrosic J; Koprowski H
    Cancer Res; 1990 Apr; 50(8):2296-302. PubMed ID: 2156614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen.
    Poole A; Gibbins JM; Turner M; van Vugt MJ; van de Winkel JG; Saito T; Tybulewicz VL; Watson SP
    EMBO J; 1997 May; 16(9):2333-41. PubMed ID: 9171347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syk tyrosine kinase required for mouse viability and B-cell development.
    Cheng AM; Rowley B; Pao W; Hayday A; Bolen JB; Pawson T
    Nature; 1995 Nov; 378(6554):303-6. PubMed ID: 7477353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fc epsilon receptors.
    Amoui M; Dráberová L; Tolar P; Dráber P
    Eur J Immunol; 1997 Jan; 27(1):321-8. PubMed ID: 9022035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.